Atnaujinkite slapukų nuostatas

El. knyga: Making and Using Antibodies: A Practical Handbook, Second Edition

Edited by (The Gladstone Institutes, San Francisco, California, USA), Edited by (Bell & Associates, San Francisco, California, USA)
  • Formatas: 458 pages
  • Išleidimo metai: 29-Jul-2013
  • Leidėjas: CRC Press Inc
  • Kalba: eng
  • ISBN-13: 9781439869109
  • Formatas: 458 pages
  • Išleidimo metai: 29-Jul-2013
  • Leidėjas: CRC Press Inc
  • Kalba: eng
  • ISBN-13: 9781439869109

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

"This second edition provides guidance on all aspects of how to make and use antibodies for research, and commercial and industrial applications. All chapters are revised, updated, or expanded. New material in the book includes western blotting, aptamers, antibodies as therapeutics, quantitative production, and humanization of antibodies. The authors present descriptions of basic methods for making and using antibodies and describe basic laboratory techniques in detail. Each chapter includes introductorymaterial, allowing for a better understanding of each concept. Practical examples are also included"--Provided by publisher.

Antibodies protect us from a wide range of infectious diseases and cancers and have become an indispensable tool in science—both for conventional immune response research as well as other areas related to protein identification analysis. This second edition of Making and Using Antibodies: A Practical Handbook provides clear guidance on all aspects of how to make and use antibodies for research along with their commercial and industrial applications.

Keeping pace with new developments in this area, all chapters in this new edition have been revised, updated, or expanded. Along with discussions of current applications, new material in the book includes chapters on western blotting, aptamers, antibodies as therapeutics, quantitative production, and humanization of antibodies. The authors present clear descriptions of basic methods for making and using antibodies and supply detailed descriptions of basic laboratory techniques. Each chapter begins with introductory material, allowing for a better understanding of each concept, and practical examples are included to help readers grasp the real-world scenarios in which antibodies play a part.

From the eradication of smallpox to combating cancer, antibodies present an attractive solution to a range of biomedical problems. They are relatively easy to make and use, have great flexibility in applications, and are cost effective for most labs. This volume will assist biomedical researchers and students and pave the way for future discovery of new methods for making and using antibodies for a host of applications.

Preface vii
Acknowledgment ix
Editors xi
Contributors xiii
Chapter 1 Antibodies
1(6)
Matthew R. Kaser
Gary C. Howard
Chapter 2 Antigens and Adjuvants
7(26)
Paul Algate
Jory Baldridge
Sally P. Mossman
Chapter 3 Production of Polyclonal Antibodies
33(34)
Lon V. Kendall
Chapter 4 Purification and Characterization of Antibodies
67(30)
Joseph P. Chandler
Chapter 5 Production of Monoclonal Antibodies
97(22)
Kathleen C. F. Sheehan
Chapter 6 Quantitative Production of Monoclonal Antibodies
119(32)
David A. Fox
Elizabeth M. Smith
Chapter 7 Making Antibodies in Bacteria
151(22)
Frederic A. Fellouse
Sachdev S. Sidhu
Chapter 8 In Vitro Selection of Aptamers
173(34)
Tianjiao Wang
Xiangyu Cong
Marit Nilsen-Hamilton
Chapter 9 Chemical and Proteolytic Modification of Antibodies
207(68)
George P. Smith
Chapter 10 Western Blots and Other Applications
275(28)
Lee Bendickson
Marit Nilsen-Hamilton
Chapter 11 Immunohistochemical Methods
303(40)
Jose A. Ramos-Vara
Chapter 12 Immunoelectron Microscopy
343(28)
Sara E. Miller
David N. Howell
Chapter 13 Flow Cytometry
371(14)
Steven B. McClellan
Chapter 14 ELISAs
385(10)
John Chen
Gary C. Howard
Chapter 15 Humanization of Antibodies
395(26)
Juan Carlos Almagro
Sreekumar Kodangattil
Jian Li
Chapter 16 Antibodies in the Future: Challenges and Opportunities
421(8)
Gary C. Howard
Matthew R. Kaser
Index 429
Matthew R. Kaser, DPhil, earned his DPhil in biochemistry from Oxford University (UK) in 1988. After postdoctoral positions at the University of California, the University of Texas, and at REI Harbor-UCLA Medical Center, he was appointed to a faculty position at the University of California, San Francisco, Department of Pediatrics, then served as a scientist and patent agent at Incyte Genomics in Palo Alto, California, and a lecturer at California Sate University East Bay, Hayward. Dr. Kaser has been practicing as a patent agent since 1999, was associate director of intellectual property at Mendel Biotechnology, Hayward, and is a senior partner at Bell & Associates in San Francisco. He has presented research papers at a number of regional, national, and international conferences and coauthored more than a dozen publications.

Gary C. Howard, PhD, earned his PhD in biological sciences from Carnegie Mellon University in 1979. He completed his postdoctoral training at Harvard University and The Johns Hopkins University and was a research assistant biochemist at the University of California, San Francisco. He then joined Vector Laboratories in Burlingame as a biochemist and Medix Biotech (a subsidiary of Genzyme) in Foster City, California, as chemistry manager and operations manager. Currently, he is manager of scientific editing at The Gladstone Institutes, a private biomedical research institute affiliated with the University of California, San Francisco.